| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.2M | — | +898.4% |
| Cost of Revenue | $1.4M | — | — |
| Gross Profit | $1.8M | — | +464.3% |
| R&D Expense | $4.2M | — | +117.7% |
| SG&A Expense | $6.3M | — | +38.1% |
| Operating Income | -$8.7M | — | -40.5% |
| Net Income | -$9.5M | — | -53.6% |
| EPS (Basic) | -$2.15 | — | -31.1% |
| EPS (Diluted) | -$2.15 | — | -31.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $23.5M | +83.4% | +591.1% |
| Accounts Receivable | $396K | — | — |
| Current Assets | $29.3M | +31.3% | +327.9% |
| Total Assets | $45.9M | +13.8% | +291.1% |
| Current Liabilities | $11.6M | -27.8% | -31.7% |
| Total Liabilities | $18.7M | -19.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.8M | — | -39.3% |
| Capital Expenditures | $197K | — | — |
| Investing Cash Flow | -$185K | — | — |
| Financing Cash Flow | $16.7M | — | +178.7% |
| Free Cash Flow | -$6.0M | — | -44.0% |
| +5.6% |
| Stockholders' Equity | $27.2M | +58.5% | +554.9% |